Clinical applications of human organoids
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“Aging is characterized by the accumulation of cellular and chromosomal damage, disrupted homeostasis and a decline in the regenerative capacity of organs 123 , processes that are well suited to analysis in organoid models.”
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · cited 1×
“Some organoid-based applications, for instance, in donor organ repair during machine perfusion 14 , are on the cusp of clinical use, while others are currently being evaluated 3 , organoids have been initiated from many tissue types using similar work-up and culture conditions.”
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472 · cited 1×
“However, in infected patients, many viruses (particularly those with pandemic potential), cause severe pathogenesis that is often accompanied by hyperinflammation 116 , which cannot be recapitulated in virus-exposed organoids.”
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973 · cited 1×
“Organoids have been established for various types of cancer including colorectal cancer 46,47 , prostate cancer 48 , pancreatic cancer 49 , gastric cancer 50,51 , liver cancer 52 , biliary tract cancer 53 , breast cancer 54 and neuroendocrine tumors 55 .”
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
SARS-CoV-2 productively infects human gut enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · Science · doi:10.1126/science.abc1669 · Cited by 1,573 · cited 1×
“In addition to the use of human airway organoids to model the primary infection of SARS-CoV-2 110 , kidney 111 , liver 112 and intestinal 113 organoids were used to recapitulate the broad tropism of this virus and understand the associated systemic manifestations.”
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
Organoid modeling of the tumor immune microenvironment
Neal, J. T., Li, X., Zhu, J., Giangarra, V., Grzeskowiak, C. L., Ju, J., Liu, I. H., Chiou, S.-H., Salahudeen, A. A., Smith, A. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.021 · Cited by 1,556 · cited 2×
“Recent studies have shown that co-culturing cancer organoids with immune cells can be used to assess the efficacy of T cell-mediated tumor killing 6,21,65,66 .”
Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., & Sasai, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.002 · Cited by 1,522
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · cited 2×
“The challenge here, and most probably in all tumor-related personalized medicine applications, is to reduce or eliminate the growth of nonmalignant cells that, in the current expansion protocol 52,53 , have a proliferative advantage at the expense of tumor cell growth.”
Self-citationDesigner matrices for intestinal stem cell and organoid culture
Gjorevski, N., Sachs, N., Manfrin, A., Giger, S., Bragina, M. E., Ordóñez-Morán, P., Clevers, H., & Lutolf, M. P. (2016) · Nature · doi:10.1038/nature20168 · Cited by 1,426 · cited 1×
“Alternative hydrogels, either synthetic 149–151 and/or organ derived 152–155 , are not yet available in large quantities of constant quality, nor is it known how long these alternative hydrogels can support organoid expansion in culture.”
Immune Checkpoint Inhibitors in Cancer Therapy
Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022) · Current Oncology · doi:10.3390/curroncol29050247 · Cited by 1,353
Replication of human noroviruses in stem cell–derived human enteroids
Ettayebi, K., Crawford, S. E., Murakami, K., Broughman, J. R., Karandikar, U., Tenge, V. R., Neill, F. H., Blutt, S. E., Zeng, X.-L., Qu, L., et al. (2016) · Science · doi:10.1126/science.aaf5211 · Cited by 1,305
Immune checkpoint therapy—current perspectives and future directions
Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.006 · Cited by 1,206
Zika virus impairs growth in human neurospheres and brain organoids
Garcez, P. P., Loiola, E. C., Madeiro da Costa, R., Higa, L. M., Trindade, P., Delvecchio, R., Nascimento, J. M., Brindeiro, R., Tanuri, A., & Rehen, S. K. (2016) · Science · doi:10.1126/science.aaf6116 · Cited by 1,184 · cited 1×
“Brain organoids were widely used to understand the causality between Zika virus and malformations in fetal brains 107 .”
Dijkstra, K. K., Cattaneo, C. M., Weeber, F., Chalabi, M., van de Haar, J., Fanchi, L. F., Slagter, M., van der Velden, D. L., Kaing, S., Kelderman, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.009 · Cited by 1,135
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
Garrett-Bakelman, F. E., Darshi, M., Green, S. J., Gur, R. C., Lin, L., Macias, B. R., McKenna, M. J., Meydan, C., Mishra, T., Nasrini, J., et al. (2019) · Science · doi:10.1126/science.aau8650 · Cited by 1,128
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0349 · Cited by 1,092
Flow-enhanced vascularization and maturation of kidney organoids in vitro
Homan, K. A., Gupta, N., Kroll, K. T., Kolesky, D. B., Skylar-Scott, M., Miyoshi, T., Mau, D., Valerius, M. T., Ferrante, T., Bonventre, J. V., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0325-y · Cited by 939 · cited 1×
“Supplementing 3D epithelial organoids with other cell types such as immune cells 21 , fibroblasts 22,23 or neural cells and adding vasculature 24 and extracellular matrix components 25 increase the complexity, providing better mimicking of tissue and disease models (Fig.”
Tissue-specific mutation accumulation in human adult stem cells during life
Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. (2016) · Nature · doi:10.1038/nature19768 · Cited by 935 · cited 1×
“Interestingly, different cell types showed different mutation spectra, which seemed to be linked to cell division rate and other intrinsic processes that can initiate tumorigenesis 124 .”
Self-citationFujii, M., Shimokawa, M., Date, S., Takano, A., Matano, M., Nanki, K., Ohta, Y., Toshimitsu, K., Nakazato, Y., Kawasaki, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.003 · Cited by 852 · cited 1×
“Organoids have been established for various types of cancer including colorectal cancer 46,47 , prostate cancer 48 , pancreatic cancer 49 , gastric cancer 50,51 , liver cancer 52 , biliary tract cancer 53 , breast cancer 54 and neuroendocrine tumors 55 .”
Seino, T., Kawasaki, S., Shimokawa, M., Tamagawa, H., Toshimitsu, K., Fujii, M., Ohta, Y., Matano, M., Nanki, K., Kawasaki, K., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.12.009 · Cited by 631 · cited 1×
“Studies using pancreatic tumor organoids have reported that CAFs secrete growth factors such as WNT, maintaining stem cell phenotypes, and that pancreatic cancer growth becomes independent of WNT during disease progression 59 .”
Kobayashi, Y., Tata, A., Konkimalla, A., Katsura, H., Lee, R. F., Ou, J., Banovich, N. E., Kropski, J. A., & Tata, P. R. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0542-8 · Cited by 559 · cited 1×
“Similarly, alveolar organoids also serve as in vitro injury repair models and revealed that persistent cell senescence could diminish alveolar regeneration, leading to pulmonary fibrosis 128 .”
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., et al. (2021) · Nature · doi:10.1038/s41586-020-2901-9 · Cited by 530 · cited 1×
“Current efforts are mainly restricted to evaluating individual antiviral agents to prevent infection 114,117 , while small-scale antiviral drug screening has been demonstrated to be feasible in virus-infected organoids 118,119 .”
Recapitulating macro-scale tissue self-organization through organoid bioprinting
Brassard, J. A., Nikolaev, M., Hübscher, T., Hofer, M., & Lutolf, M. P. (2021) · Nature Materials · doi:10.1038/s41563-020-00803-5 · Cited by 469 · cited 1×
“Overall, the self-organization behavior achieved by combining bioprinting with organoid-forming cells takes the (microscale) complexity of the modeled tissues to levels not usually attainable by traditional, manual approaches 31 .”
Boretto, M., Cox, B., Noben, M., Hendriks, N., Fassbender, A., Roose, H., Amant, F., Timmerman, D., Tomassetti, C., Vanhie, A., et al. (2017) · Development · doi:10.1242/dev.148478 · Cited by 459
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
Schuster, B., Junkin, M., Kashaf, S. S., Romero-Calvo, I., Kirby, K., Matthews, J., Weber, C. R., Rzhetsky, A., White, K. P., & Tay, S. (2020) · Nature Communications · doi:10.1038/s41467-020-19058-4 · Cited by 424
Cholangiocyte organoids can repair bile ducts after transplantation in the human liver
Sampaziotis, F., Muraro, D., Tysoe, O. C., Sawiak, S., Beach, T. E., Godfrey, E. M., Upponi, S. S., Brevini, T., Wesley, B. T., Garcia-Bernardo, J., et al. (2021) · Science · doi:10.1126/science.aaz6964 · Cited by 394 · cited 4×
“Repairing damaged bile ducts, for instance, to regenerate otherwise discarded donor livers, requires millions of cells 14 to be effective.”
InfluentialHuman tissues in a dish: The research and ethical implications of organoid technology
Bredenoord, A. L., Clevers, H., & Knoblich, J. A. (2017) · Science · doi:10.1126/science.aaf9414 · Cited by 334 · cited 3×
“The development and use of organoids raise ethical issues 156–158 , which may differ according to organoid type and application.”
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
Marsee, A., Roos, F. J. M., Verstegen, M. M. A., Marsee, A., Roos, F., Verstegen, M., Clevers, H., Vallier, L., Takebe, T., Huch, M., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.005 · Cited by 310 · cited 1×
“The identification of isolated biological processes driving disease development and of cell types, including non-epithelial cells 2 .”
Self-citationNotum produced by Paneth cells attenuates regeneration of aged intestinal epithelium
Pentinmikko, N., Iqbal, S., Mana, M., Andersson, S., Cognetta, A. B., Suciu, R. M., Roper, J., Luopajärvi, K., Markelin, E., Gopalakrishnan, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1383-0 · Cited by 271 · cited 1×
“Moreover, intestinal organoids have been used to identify the regulatory role of defects in intestinal stem cells and their niches in the aging intestinal epithelium 127 .”
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
Jansen, J., Reimer, K. C., Nagai, J. S., Varghese, F. S., Overheul, G. J., de Beer, M., Roverts, R., Daviran, D., Fermin, L. A. S., Willemsen, B., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.010 · Cited by 259
An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping
Kawasaki, K., Toshimitsu, K., Matano, M., Fujita, M., Fujii, M., Togasaki, K., Ebisudani, T., Shimokawa, M., Takano, A., Takahashi, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.023 · Cited by 238 · cited 1×
“Organoids have been established for various types of cancer including colorectal cancer 46,47 , prostate cancer 48 , pancreatic cancer 49 , gastric cancer 50,51 , liver cancer 52 , biliary tract cancer 53 , breast cancer 54 and neuroendocrine tumors 55 .”
Self-citationLamers, M. M., van der Vaart, J., Knoops, K., Riesebosch, S., Breugem, T. I., Mykytyn, A. Z., Beumer, J., Schipper, D., Bezstarosti, K., Koopman, C. D., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105912 · Cited by 227
Incidence of clinical symptoms during long-duration orbital spaceflight
Crucian, B., Babiak-Vazquez, A., Johnston, S., Pierson, D., Ott, C. M., & Sams, C. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s114188 · Cited by 223
Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer
Lõhmussaar, K., Oka, R., Espejo Valle-Inclan, J., Smits, M. H. H., Wardak, H., Korving, J., Begthel, H., Proost, N., van de Ven, M., Kranenburg, O. W., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.012 · Cited by 211
Large‐Scale Production of LGR5‐Positive Bipotential Human Liver Stem Cells
Schneeberger, K., Sánchez‐Romero, N., Ye, S., van Steenbeek, F. G., Oosterhoff, L. A., Pla Palacin, I., Chen, C., van Wolferen, M. E., van Tienderen, G., Lieshout, R., et al. (2020) · Hepatology · doi:10.1002/hep.31037 · Cited by 141
Self-citationHydrogel-in-hydrogel live bioprinting for guidance and control of organoids and organotypic cultures
Urciuolo, A., Giobbe, G. G., Dong, Y., Michielin, F., Brandolino, L., Magnussen, M., Gagliano, O., Selmin, G., Scattolini, V., Raffa, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37953-4 · Cited by 121
Rosendahl Huber, A., Pleguezuelos-Manzano, C., Puschhof, J., Ubels, J., Boot, C., Saftien, A., Verheul, M., Trabut, L. T., Groenen, N., van Roosmalen, M., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.02.009 · Cited by 106
Willemse, J., van Tienderen, G., van Hengel, E., Schurink, I., van der Ven, D., Kan, Y., de Ruiter, P., Rosmark, O., Westergren-Thorsson G, G., Schneeberger, K., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121473 · Cited by 106
Self-citationMpox virus infection and drug treatment modelled in human skin organoids
Li, P., Pachis, S. T., Xu, G., Schraauwen, R., Incitti, R., de Vries, A. C., Bruno, M. J., Peppelenbosch, M. P., Alam, I., Raymond, K., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01489-6 · Cited by 77 · cited 2×
“During the ongoing global mpox outbreak, human skin organoids have been shown to effectively support mpox virus infection, recapitulating the primary infection in patient skin 114 .”
Self-citationKwong, J., Chan, F. L., Wong, K.-K., Birrer, M. J., Archibald, K. M., Balkwill, F. R., Berkowitz, R. S., & Mok, S. C. (2009) · Neoplasia · doi:10.1593/neo.09112 · Cited by 62 · cited 1×
“Epithelial organoids have been established to model the different regions of the female reproductive tract such as the ovaries 72,73 , fallopian tubes 74,75 , endometrial tissue 76–78 , the cervix 79–81 and placental trophoblasts 82,83 .”
Abaza, A., Sid Idris, F., Anis Shaikh, H., Vahora, I., Moparthi, K. P., Al Rushaidi, M. T., Muddam, M. R., Obajeun, O. A., Jaramillo, A. P., & Khan, S. (2023) · Cureus · doi:10.7759/cureus.44582 · Cited by 59 · cited 1×
“https://doi.org/10.1038/s41591-024-03489-3 inhibitors that block the binding of the immune checkpoint molecules PD-1 or CTLA-4 and their ligands demonstrate potent anti-tumor effects in some cancers through activation of cancer antigen-specific cytotoxic T cells 60–63 .”
Influentialvan Tienderen, G. S., Rosmark, O., Lieshout, R., Willemse, J., de Weijer, F., Elowsson Rendin, L., Westergren-Thorsson, G., Doukas, M., Groot Koerkamp, B., van Royen, M. E., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.038 · Cited by 47 · cited 3×
“Innovative technical advances include augmenting organoids with multiple cell types 5–7 and the development of organ-specific extracellular matrix to increase complexity and better mimic various healthy or diseased tissues 8,9 .”
Self-citationWillemse, J., Roos, F. J. M., Voogt, I. J., Schurink, I. J., Bijvelds, M., de Jonge, H. R., van der Laan, L. J. W., de Jonge, J., & Verstegen, M. M. A. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27613 · Cited by 35
Self-citation
Metadata
- Authors
- Verstegen, M. M. A., Coppes, R. P., Beghin, A., De Coppi, P., Gerli, M. F. M., de Graeff, N., Pan, Q., Saito, Y., Shi, S., Zadpoor, A. A., & van der Laan, L. J. W.
- Venue
- Nature Medicine
- Published
- 2025-02
- Volume
- 31
- Issue
- 2
- Pages
- 409-421
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4407108225
- Cited by
- 206
- References
- 47
- FWCI
- 48.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.